Table 1. Clinicopathological variables related to L1CAM status in curettage specimens for women operated for endometrial cancer.
L1CAM |
|||
---|---|---|---|
Variable | Low (0–3), n (%) | High (4–9), n (%) | P-value |
Age (years) | <0.001 | ||
<66 | 520 (95) | 30 (5) | |
⩾66 | 480 (82) | 104 (18) | |
Information available preoperatively | |||
Curettage histologya | <0.001 | ||
Low risk | 811 (95) | 40 (5) | |
High risk | 170 (64) | 94 (36) | |
PR curettage | <0.001 | ||
Positive | 795 (96) | 36 (4) | |
Negative | 191 (69) | 88 (31) | |
ER-α curettage | <0.001 | ||
Positive | 746 (95) | 43 (5) | |
Negative | 228 (72) | 89 (28) | |
Information available postoperatively | |||
FIGO-09 stage | <0.001 | ||
I–II | 872 (91) | 84 (9) | |
III–IV | 128 (72) | 50 (28) | |
Histologic type | <0.001 | ||
Endometrioid | 874 (96) | 36 (4) | |
Adenosquamous | 10 (91) | 1 (9) | |
Clear cell | 29 (71) | 12 (29) | |
Serous papillary | 39 (36) | 70 (64) | |
Carcinosarcoma | 35 (76) | 11 (24) | |
Undifferentiated/other | 13 (77) | 4 (23) | |
Histologic gradeb | <0.001 | ||
Grade 1/2 | 754 (97) | 21 (3) | |
Grade 3 | 120 (86) | 19 (14) | |
Metastatic nodes | <0.001 | ||
Negative | 657 (92) | 60 (8) | |
Positive | 77 (72) | 30 (28) | |
Myometrial infiltration | <0.001 | ||
<50% | 608 (92) | 51 (8) | |
⩾50% | 309 (84) | 60 (16) | |
Ploidy | <0.001 | ||
Diploid | 288 (94) | 17 (6) | |
Aneuploid | 49 (58) | 35 (42) | |
L1CAM hysterectomy specimen | <0.001 | ||
Low | 431 (96) | 16 (4) | |
High | 26 (36) | 46 (64) |
Abbreviations: ER=oestrogen receptor; FIGO=Federation of Gynaecology and Obstetrics; L1CAM=L1 cell adhesion molecule; PR=progesterone receptor.
Missing information on curettage histology classification for 19 patients, PR status in curettage for 24 patients, ER-α status in curettage for 28 patients, grade for 9 patients, metastatic nodes for 310 patients, myometrial infiltration for 106 patients, ploidy for 745 patients and L1CAM status in hysterectomy specimen for 615 patients.
Curettage histological risk classification, low risk (benign, hyperplasia or endometrioid grades 1–2) or high risk (non-endometrioid or endometrioid grade 3).
Only endometrioid.